# Effect of Mepolizumab on Severe Eosinophilic Asthma

> **NCT04641741** · — · UNKNOWN · sponsor: **Hospital Clinico Universitario de Santiago** · enrollment: 30 (estimated)

## Conditions studied

- Asthma
- Eosinophilic Asthma

## Interventions

- **DRUG:** Mepolizumab 100 MG

## Key facts

- **NCT ID:** NCT04641741
- **Lead sponsor:** Hospital Clinico Universitario de Santiago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04641741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04641741, "Effect of Mepolizumab on Severe Eosinophilic Asthma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04641741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*